One in 10 people live with the fear of accidental exposures to things like peanuts, eggs or milk. An EpiPen is always at ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

This review discusses the evolution, challenges, and innovations of antibody-drug conjugates (ADCs) in cancer treatment. It ...

A powerful one-and-done gene therapy shuttle, suitable for remote settings, can prevent HIV transmission from mothers to ...

New research in mice reveals that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory ...

A Northwestern study found that the asthma drug zileuton prevents food allergy anaphylaxis in mice by blocking allergen absorption in the gut. The research reveals a new mechanism driving allergic ...

Shares of US clinical-stage company Eledon Pharmaceuticals shot up 9.9% to close at $3.44 yesterday, after it announced ...

New research in mice reveals that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory lipids called leukotrienes ...

Christopher Cano has been picked as the new Chief Executive Officer of Cellergy Pharma Inc., a preclinical biotechnology firm ...

The emerging role of SETD2 in regulating immune cell function is shedding light on potential therapeutic strategies for a ...

Public Health experts have reiterated the importance of exclusive breastfeeding, as a natural, cost-effective, and ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow disability progression.